Manchester Capital Management LLC Horizon Therapeutics Public LTD CO Transaction History

Manchester Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$86.42 - $109.81 $13,740 - $17,459	-159 Reduced 3.83%	3,989 $420,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $29,043 - $34,876	316 Added 8.25%	4,148 $454,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $1,638 - $1,822	19 Added 0.5%	3,832 $359,000
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $1,795 - $2,387	-25 Reduced 0.65%	3,813 $351,000
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $1,407 - $1,772	21 Added 0.55%	3,838 $281,000
Q3 2020 Oct 27, 2020	BUY	$55.23 - $79.93 $210,812 - $305,092	3,817 New	3,817 $297,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Manchester Capital Management LLC with notifications on news.